May 2026 Research Update

This month, a single detailed report connected an early pregnancy ultrasound finding to a specific, newly occurring change in the TCF4 gene that interfered with how the gene is read. The key addition is that the study did not stop at finding a DNA change; it also tested how that change affected the gene message and showed it caused abnormal splicing. This makes the genetic finding feel more biologically grounded, even though it is still only one pregnancy and may not apply broadly. [1]

In this twin pregnancy, one fetus had increased nuchal translucency on ultrasound, and genetic testing on amniotic fluid identified a de novo (new, not inherited) TCF4 splice-site variant, c.1146+3A>T. A lab splicing experiment (a minigene assay) showed this variant led to skipping of exon 14 and produced a truncated TCF4 transcript, which is a clear type of disruption that can fit with TCF4-related conditions such as Pitt-Hopkins syndrome. The study also showed the variant was not present in either parent, supporting that it arose new in the fetus. [1]

For families, this report mainly adds to understanding of how Pitt-Hopkins syndrome might sometimes first come to attention during pregnancy and how a suspected gene change can be checked for real biological impact. It may matter now for awareness that an ultrasound finding like increased nuchal translucency can sometimes be part of the pathway that leads to genetic testing, but it does not show how often this happens or what outcomes follow. What remains uncertain is how common this type of prenatal presentation is in Pitt-Hopkins syndrome, and whether this specific variant leads to the typical range of Pitt-Hopkins features after birth. [1]

This month included early laboratory research asking a basic question: can a common brain form of the TCF4 protein gather into droplet-like clusters, and does DNA affect that behavior? The study reported that TCF4 did form dynamic clusters in a test-tube system and that adding DNA could dissolve them. This does not tell us what happens in people, but it offers a possible way to think about how TCF4 might organize gene control inside cells. [2]

The researchers observed that the TCF4 isoform they studied formed liquid-like condensates that could merge together and still had signs of internal movement over time. They also reported that these condensates became more viscous as they matured, and that both specific and non-specific DNA sequences dissolved the condensates. In plain language, this suggests TCF4 clustering in this system is sensitive to DNA and may depend on the parts of the protein that interact with DNA and flexible regions of the protein. [2]

For patients and caregivers, this is mainly background research that may matter later if it is confirmed in living cells and connected to symptoms. It helps clarify one possible mechanism for how TCF4 could regulate other genes in the brain, which is central to Pitt-Hopkins syndrome, but it does not yet explain day-to-day features or point to a tested therapy. What remains uncertain is whether the same droplet-like behavior happens in the brain and whether Pitt-Hopkins-related TCF4 changes alter this process in a meaningful way. [2]